Northern Trust
TCRT icon

Northern Trust’s Alaunos Therapeutics TCRT Stock Holding History

Northern Trust’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,898
Closed -$20.3K – 4451
2024
Q2 		$20.3K Sell
2,898
-5
-0.2% -$60 ﹤0.01% 4330
2024
Q1 		$52.6K Sell
2,903
-1
-0% -$20 ﹤0.01% 4219
2023
Q4 		$30.8K Hold
2,904
– – ﹤0.01% 4316
2023
Q3 		$57.4K Sell
2,904
-30
-1% -$1.29K ﹤0.01% 4136
2023
Q2 		$224K Sell
2,934
-6
-0.2% -$485 ﹤0.01% 3783
2023
Q1 		$278K Buy
2,940
+103
+4% +$9.81K ﹤0.01% 3708
2022
Q4 		$276K Sell
2,837
-7
-0.2% -$1.01K ﹤0.01% 3726
2022
Q3 		$734K Sell
2,844
-25
-0.9% -$7.26K ﹤0.01% 3394
2022
Q2 		$534K Sell
2,869
-11,532
-80% -$1.1M ﹤0.01% 3516
2022
Q1 		$1.41M Sell
14,401
-1,166
-7% -$150K ﹤0.01% 3265
2021
Q4 		$2.54M Buy
15,567
+1,126
+8% +$247K ﹤0.01% 3108
2021
Q3 		$3.94M Sell
14,441
-869
-6% -$266K ﹤0.01% 2881
2021
Q2 		$6.06M Sell
15,310
-506
-3% -$236K ﹤0.01% 2731
2021
Q1 		$8.54M Sell
15,816
-593
-4% -$369K ﹤0.01% 2397
2020
Q4 		$6.2M Sell
16,409
-1,111
-6% -$442K ﹤0.01% 2550
2020
Q3 		$6.62M Sell
17,520
-689
-4% -$304K ﹤0.01% 2364
2020
Q2 		$8.96M Buy
18,209
+2,329
+15% +$1.04M ﹤0.01% 2161
2020
Q1 		$5.84M Buy
15,880
+1,992
+14% +$1.03M ﹤0.01% 2205
2019
Q4 		$9.83M Buy
13,888
+266
+2% +$183K ﹤0.01% 2190
2019
Q3 		$8.75M Buy
13,622
+2,180
+19% +$1.73M ﹤0.01% 2233
2019
Q2 		$10M Buy
11,442
+333
+3% +$229K ﹤0.01% 2154
2019
Q1 		$6.42M Buy
11,109
+124
+1% +$51.8K ﹤0.01% 2412
2018
Q4 		$3.08M Buy
10,985
+54
+0.5% +$21.3K ﹤0.01% 2801
2018
Q3 		$5.25M Buy
10,931
+109
+1% +$46.7K ﹤0.01% 2657
2018
Q2 		$4.9M Buy
10,822
+286
+3% +$181K ﹤0.01% 2690
2018
Q1 		$6.2M Buy
10,536
+65
+0.6% +$40.5K ﹤0.01% 2457
2017
Q4 		$6.5M Sell
10,471
-341
-3% -$245K ﹤0.01% 2443
2017
Q3 		$9.96M Sell
10,812
-60
-0.6% -$53.3K ﹤0.01% 2211
2017
Q2 		$10.1M Buy
10,872
+993
+10% +$973K ﹤0.01% 2174
2017
Q1 		$9.39M Buy
9,879
+438
+5% +$408K ﹤0.01% 2163
2016
Q4 		$7.58M Buy
9,441
+134
+1% +$121K ﹤0.01% 2285
2016
Q3 		$7.86M Sell
9,307
-275
-3% -$221K ﹤0.01% 2225
2016
Q2 		$7.89M Buy
9,582
+403
+4% +$439K ﹤0.01% 2177
2016
Q1 		$10.2M Buy
9,179
+52
+0.6% +$53.2K ﹤0.01% 1962
2015
Q4 		$11.4M Buy
9,127
+628
+7% +$1.04M ﹤0.01% 1929
2015
Q3 		$11.5M Buy
8,499
+1,151
+16% +$1.9M ﹤0.01% 1897
2015
Q2 		$13.2M Buy
7,348
+445
+6% +$691K ﹤0.01% 1878
2015
Q1 		$11.2M Buy
6,903
+927
+16% +$1.37M ﹤0.01% 2005
2014
Q4 		$4.54M Sell
5,976
-211
-3% -$112K ﹤0.01% 2574
2014
Q3 		$2.45M Sell
6,187
-134
-2% -$64.6K ﹤0.01% 2969
2014
Q2 		$3.82M Sell
6,321
-875
-12% -$487K ﹤0.01% 2704
2014
Q1 		$4.94M Sell
7,196
-218
-3% -$146K ﹤0.01% 2568
2013
Q4 		$4.83M Buy
7,414
+1,099
+17% +$654K ﹤0.01% 2594
2013
Q3 		$3.73M Buy
6,315
+15
+0.2% +$6.76K ﹤0.01% 2701
2013
Q2 		$1.99M Buy
+6,300
New +$1.75M ﹤0.01% 2991

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SWM
Sugarloaf Wealth Management Duluth, Georgia $529M AUM 14.14% 1-Year Est. Return

Northern Trust's TCRT Position: Q3 2024 in Review

Northern Trust sold out of Alaunos Therapeutics (TCRT) in Q3 2024, closing a stake of 2,898 shares — an estimated $20.3K sold.

Northern Trust first reported a position in TCRT in Q2 2013 and held it in 45 quarters. The position peaked at $13.2M in Q2 2015. 29 funds tracked by Wall St. Rank hold TCRT as of Q3 2024.

  • Northern Trust reported no remaining Alaunos Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Northern Trust sold 2,898 Alaunos Therapeutics shares in Q3 2024, an estimated $20.3K.
  • Northern Trust first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 45 quarters.
  • Northern Trust's Alaunos Therapeutics position peaked at $13.2M in Q2 2015.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2024.

Based on Northern Trust's 13F filing for Q3 2024, filed 13 Nov 2024.